Oral BVDU treatment of varicella and zoster in children with cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology, and Child Health
Link
http://link.springer.com/content/pdf/10.1007/BF00442138.pdf
Reference35 articles.
1. Allaudeen HS, Kozarich JW, Bertino JR, De Clercq E (1981) On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2?-deoxyuridine. Proc Natl Acad Sci USA 78:2698?2702
2. Allaudeen HS, Chen MS, Lee JJ, De Clercq E, Prusoff WH (1982) Incorporation of E-5-(2-halovinyl)-2?-deoxyuridines into deoxyribonucleic acids of herpes simplex virus type 1-infected cells. J Biol Chem 257:603?606
3. Balfour HH Jr (1984) Intravenous acyclovir therapy for varicella in immunocompromised children. J Pediatr 104:134?136
4. Balfour HH Jr, Bean B, Laskin OL, Ambinder RF, Meyers JD, Wade JC, Zaia JA, Aeppli D, Kirk LE, Segreti AC, Keeney RE, The Burroughs Wellcome Collaborative Acyclovir Study Group (1983) Acyclovir halts progression of herpes zoster in immunocompromised patients. New Engl J Med 308:1448?1453
5. Balfour HH Jr, McMonigal KA, Bean B (1983) Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients. J Antimicrob Chemother 12 [Suppl B]:169?179
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment with Brivudine in Immunocompromised Pediatric Patients with Herpes Zoster;Chemotherapy;2023-05-18
2. Intestinal Apc ‐inactivation induces HSP25 dependency;EMBO Molecular Medicine;2022-11-02
3. Treatment of herpes zoster with brivudin in immunocompromised children;2022-10-12
4. Cell Fate Control Gene Therapy Based on Engineered Variants of Human Deoxycytidine Kinase;Molecular Therapy;2012-05
5. Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer;Cancer Gene Therapy;2012-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3